{"id":1016055,"date":"2026-11-02T09:27:05","date_gmt":"2026-11-02T14:27:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/"},"modified":"2026-11-02T09:27:05","modified_gmt":"2026-11-02T14:27:05","slug":"crescent-biopharma-to-present-at-november-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/","title":{"rendered":"Crescent Biopharma to Present at November Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jvFdWIL2hfK35-QvVMxHp-8B5YZ-SGveW_sSBljvPAy1SMbAEQ8Qiyh80T7yYvpQhyA2gKNc-jUs1GK52zbaWqZC-2MU55iw0KTy64sOo_LXPLBwcXF0-D6HEh3QHoDa\" rel=\"nofollow\" target=\"_blank\">Crescent Biopharma, Inc.<\/a> (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Guggenheim 3rd Annual Healthcare Innovation Conference, <\/strong>fireside chat on Monday, November 9, 2026 at 8:30 a.m. ET in Boston.<\/li>\n<li>\n          <strong>Stifel 2026 Healthcare Conference, <\/strong>fireside chat on Tuesday, November 10, 2026 at 1:20 p.m. ET in New York.<\/li>\n<li>\n          <strong>Jefferies Global Healthcare Conference,<\/strong> fireside chat on Wednesday, November 18, 2026 at 3:00 p.m. GMT\/10:00 a.m. ET in London.<\/li>\n<\/ul>\n<p>A live webcast of each presentation will be available in the Investors section of the Company&#8217;s website at<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6YfEtRYK01Cz3Zq9PtMKouk0lzblJRARrHLhjhA-P51a01tFIxh8uSPmrXvyQMFSVK2YM9qDUk_Ofjerzoqe0Xk33wz98CTVFrQu1Jn04NyN4E_qdX_-ERASfvs0_YGoBQ_6GD5ygCypoLn8enxmIg==\" rel=\"nofollow\" target=\"_blank\"> https:\/\/investors.crescentbiopharma.com\/events-presentations<\/a>, and a replay will be accessible for 90 days.<\/p>\n<p>\n        <strong>About Crescent Biopharma<\/strong>\n      <\/p>\n<p>Crescent Biopharma\u2019s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company\u2019s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VyZe8Wyw1hC67U5Vmxjd6dxBCSComLT2dJjkqxPydkNx0c-tXb_A7aiEcJ2JZkEK7afKkvlL2q0cgpP2_Ul8ZY8Ji8QjsxOlEJ8j2OmoqEaQDZK8LXjh57-Woa-c9beI\" rel=\"nofollow\" target=\"_blank\">www.crescentbiopharma.com<\/a>\u00a0and follow the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5fodVv4sPnoD3pxaAyU2_yq64KmSCNEHQpxmGI0zcl4yAoWggn6v6Wqq2h5qX-yQQQxICfgDuXl_Z3mRXwmj2kby0P7tdKmzGqwFH7-DuQPN9s3oEuSnhb3me35mmplF\" rel=\"nofollow\" target=\"_blank\">LinkedIn\u00a0<\/a>and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-lNiycUcPUG2aGPnI5hk7qj2QQ63ZE52GH7RvtKu5o_syKzlYcWuNvw5yOw36_aLynJD6axzTRO6Y54PZDzX0Q==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Amy Reilly<br \/>Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0oXoRRfTxpSOKf8-k6b5kHUTEIBp83y-k7pIsbH56POoIRH1dGzInHx2m4JdIk3D-qG44D0i2T4fr5YutSmffHvPXTXuhSjoP8EshIX0bWk8bjhTpfNALt96paYpyRUzhWcw9lPv57FCbqWOGMW9TQ==\" rel=\"nofollow\" target=\"_blank\">amy.reilly@crescentbiopharma.com<\/a><br \/>617-465-0586<\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Jenna Poist<br \/>Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AhfFVixkolmXtz7PoFqmNRTBRjZxH_8ciY21WEel21KkJUCq71RNLHBzl8SkveiTJMCG1a9ZIrvp8wg7vBxjd9u2bfTpMrqUHUSTvitBxsL1Ip7b-280K25LCOVQpdjkFK_zGwcIGBB-E1zV6hsslQ==\" rel=\"nofollow\" target=\"_blank\">jenna.poist@crescentbiopharma.com<\/a><br \/>781-671-5019<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmM0NjgxZGItNjM5Zi00MmVkLWExZDYtYmVhOGM3MjdhMzNmLTEzMTAwMzAtMjAyNi0xMS0wMi1lbg==\/tiny\/Crescent-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference, fireside chat on Monday, November 9, 2026 at 8:30 a.m. ET in Boston. Stifel 2026 Healthcare Conference, fireside chat on Tuesday, November 10, 2026 at 1:20 p.m. ET in New York. Jefferies Global Healthcare Conference, fireside chat on Wednesday, November 18, 2026 at 3:00 p.m. GMT\/10:00 a.m. ET in London. A live webcast of each presentation will be available in the Investors section of the Company&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crescent Biopharma to Present at November Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016055","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference, fireside chat on Monday, November 9, 2026 at 8:30 a.m. ET in Boston. Stifel 2026 Healthcare Conference, fireside chat on Tuesday, November 10, 2026 at 1:20 p.m. ET in New York. Jefferies Global Healthcare Conference, fireside chat on Wednesday, November 18, 2026 at 3:00 p.m. GMT\/10:00 a.m. ET in London. A live webcast of each presentation will be available in the Investors section of the Company&#8217;s &hellip; Continue reading &quot;Crescent Biopharma to Present at November Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T14:27:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crescent Biopharma to Present at November Investor Conferences\",\"datePublished\":\"2026-11-02T14:27:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/\"},\"wordCount\":251,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/\",\"name\":\"Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\",\"datePublished\":\"2026-11-02T14:27:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-november-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crescent Biopharma to Present at November Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference, fireside chat on Monday, November 9, 2026 at 8:30 a.m. ET in Boston. Stifel 2026 Healthcare Conference, fireside chat on Tuesday, November 10, 2026 at 1:20 p.m. ET in New York. Jefferies Global Healthcare Conference, fireside chat on Wednesday, November 18, 2026 at 3:00 p.m. GMT\/10:00 a.m. ET in London. A live webcast of each presentation will be available in the Investors section of the Company&#8217;s &hellip; Continue reading \"Crescent Biopharma to Present at November Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T14:27:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crescent Biopharma to Present at November Investor Conferences","datePublished":"2026-11-02T14:27:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/"},"wordCount":251,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/","name":"Crescent Biopharma to Present at November Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=","datePublished":"2026-11-02T14:27:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NjU5MCM3OTI0OTUzIzIyOTg0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-november-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crescent Biopharma to Present at November Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016055"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016055\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}